Stock Events

Stock Events

Quince Therapeutics (QNCX) Q3 2026 Earnings

14AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-28.02

6.52

41.06

75.6

Details

Expected EPS

-28.02

Actual EPS

-12.31

Surprise EPS

15.71

Surprise Percent

+56.07%

Description

Quince Therapeutics (QNCX) has reported earnings of -12.31 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.